The influence of smoking and other cofactors on the time to onset to cervical cancer in a southern European population

European Journal of Cancer Prevention

Volumn 14, Issue 5, 2005, Pages 485-491

  Matos, A ^a   Moutinho, J ^a   Pinto, D ^a   Medeiros, Rui ^a  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

Author keywords

Cervical cancer; Human papillomavirus; Oral contraceptives; Portugal; Smoke; Time to onset; Tobacco

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DISEASE SEVERITY; EUROPE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PORTUGAL; PREGNANCY; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SMOKING; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; UTERINE CERVIX CANCER; UTERINE CERVIX TUMOR;

EID: 26444545415     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cej.0000174780.44260.32     Document Type: Article

References (79)

1. Agorastos T, Lambropoulos AF, Constantinidis TC, et al. (2000). p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women. Eur J Cancer Prev 9: 113-118.
2. Arias-Pulido H, Joste N, Wheeler CM (2004). Loss of heterozygosity on chromosome 6 in HPV-16 positive cervical carcinomas carrying the DRB1*1501-DQB1*0602 haplotype. Genes Chromosomes Cancer 40: 277-284.
3. Autier P, Coibion M, Huet F, Grivegnee AR (1996). Transformation zone location and intraepithelial neoplasia of the cervix uteri. Br J Cancer 74: 488-490.
4. Barton SE, Maddox PH, Jenkins D, et al. (1988). Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change? Lancet 17: 652-654.
5. Becker TM, Wheeler CM, McGough NS (1994). Cigarette smoking and other risk factors for cervical displasia in southwestern hispanic and non hispanic white women. Cancer Epidemiol Biomarkers Prev 3: 113-119.
6. Bosch FX, Munoz N, de Sanjose S, et al. (1992). Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 52: 750-758.
7. Bosch FX, Lorincz A, Munoz N, Meijer C, Shah K (2002). The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55: 244-265.
8. Brinton LA, Hamman RF, Huggins GR, et al. (1987). Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J Natl Cancer Inst 79: 23-30.
9. Brinton LA, Reeves WC, Brenes MM, et al. (1989). Parity as a risk factor for cervical cancer. Am J Epidemiol 130: 486-496.
10. Brisson J, Morin C, Fortier M, et al. (1994). Risk factors for cervical intraepithelial neoplasia: differences between low and high grade lesions. Am J Epidemiol 140: 700-710.
11. Calhoun ES, McGovern RM, Janney CA, et al. (2002). Host genetic polymorphism analysis in cervical cancer. Clin Chem 48: 1218-1224.
12. Cavalieri E, Frenkel K, Liehr JG, et al. (2000). Estrogens as endogenous genotoxic agents - DNA adducts and mutations. J Natl Cancer Inst: Monographs 27: 75-93.
13. Chan JK, Monk BJ, Brewer C, Keefe KA, et al. (2003). HPV infection and number of lifetime sexual partners are strong predictors for natural regression of CIN 2 and 3. Br J Cancer 89: 1062-1066.
14. Costa S, Medeiros R, Vasconcelos A, et al. (2002). A slow acetylator genotype associated with an increased risk of advanced cervical cancer. J Cancer Res Clin Oncol 128: 678-682.
15. Cox JT (1995). Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus. Baillière's Clin Obstet Gynaecol 9: 1-37.
16. Craveiro R, Costa S, Pinto D, et al. (2004). TP73 alterations in cervical carcinoma. Cancer Genet Cytogenet 150: 116-121.
17. Cuzick J, Singer A, De Stavola BL, et al. (1990). Case control study of risk factors for cervical intraepithelial neoplasia in young women. Eur J Cancer 26: 684-690.
18. Cuzick J, Terry G, Ho L, et al. (2000). Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br J Cancer 82: 1348-1352.
19. Daly SF, Doyle M, English J, et al. (1998). Can the number of cigarettes smoked predict high-grade cervical intraepithelial neoplasia among women with mildly abnormal cervical smears? Am J Obstet Gynecol 179: 3999-3402.
20. de Villiers EM (2003). Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma. Int J Cancer 103: 705-708.
21. de Vet HC, Sturmans F, Knipschild PG (1994). The role of cigarette smoking in the aetiology of cervical displasia. Epidemiology 5: 631-633.
22. Deacon JM, Evans CD, Yule R, et al. (2000). Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN 3 among those infected: a case control study nested within Manchester cohort. Br J Cancer 88: 1565-1572.
23. Elandt-Johnson R, Johnson N (1980). Age of onset distributions. In: Elandt-Johnson R, Johnson N (editors): Survival models and data analysis. New York: John Wiley & Sons; pp. 392-413.
24. Elson DA, Riley RR, Lacey A, et al. (2000). Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis. Cancer Res 60: 267-1275.
25. Ferreira PM, Medeiros R, Vasconcelos A, et al. (2003). Association between CYP2E1 polymorphisms and susceptibility to prostate cancer. Eur J Cancer Prev 12: 205-211.
26. Franco EL, Duarte-Franco E, Ferenczy A (2001) Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ 164: 1017-1025.
27. Franco EL, Schaech NF, Sallow D (2003). The epidemiology of cervical cancer. Cancer J 9: 348-359.
28. Gostout BS, Poland GA, Calhoun ES, et al. (2003). TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk. Gynecol Oncol 88: 326-332.
29. Gram IT, Austin H, Stalsberg H (1992). Cigarette smoking and the incidence of cervical neoplasia, grade III, and cancer of the cervix uteri. Am J Epidemiol 135: 341-346.
30. Green J, Berrington de Gonzalez A, Smith JS, et al. (2003). Human papillomavirus infection and use of oral contraceptives. Br J Cancer 88: 1713-1720.
31. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC (2002). Production and actions of estrogens. New Engl J Med 346: 340-352.
32. Harris TG, Kulasingan SL, Kiviat NB, et al. (2004). Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia. Am J Epidemiol 159: 834-842.
33. Haverkos H, Rohrer M, Pickworth W (2000). The cause of invasive cervical cancer could be multifactorial. Biomed Pharmacother 54: 54-59.
34. Hildesheim A, Wang SS (2002). Host and viral genetics and risk of cervical cancer: a review. Virus Res 89: 229-240.
35. Hinkula M, Pukkula E, Kyyrönen P, et al. (2004). A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland. Br J Cancer 90: 1025-1029.
36. Ho GF, Burk RD, Klein S, Kadish A, et al. (1995). Persistent genital human papillomavirus infection as a risk factor for persistent cervical displasia. J Natl Cancer Inst 87: 1365-1371.
37. Ho GY, Kadish AS, Jenkins D, et al. (1998). HPV16 and cigarette smoking are risk factors for high-grade cervical intraepithelial neoplasia. Int J Cancer 18: 281-285.
38. Jin L, Qi M, Chen D-Z, Anderson A, et al. (1999). Indole-3-carbinol prevents cervical cancer in human papillomavirus type 16 (HPV16) transgenic mice. Cancer Res 59: 3991-3997.
39. Kahn JA, Rosenthal SL, Succop PA, et al. (2002). Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection. Pediatrics 109: E5.
40. Kaplan EL, Meier P (1958). Non parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481.
41. Kataja V, Syrjanen S, Yliskoski M, et al. (1993) Risk factors associated with human papillomavirus infections: a case-control study. Am J Epidemiol 138: 735-745.
42. Kjellberg L, Hallmans G, Ahren AM, et al. (2000) Smoking, diet, pregnancy, and oral contraceptive use as risk factors for cervical intraepithelial neoplasia in relation to human papillomavirus infection. Br J Cancer 82: 1332-1338.
43. La Vecchia C, Bosetti C (2003). Oral contraceptives and cervical cancer: public health implications. Eur J Cancer Prev 12: 1-2.
44. La Vecchia C, Franceschi S, Decarli A et al. (1986). Cigarette smoking and the risk of cervical neoplasia. Am J Epidemiol 123: 22-29.
45. La Vecchia C, Negri E, Franceschi S, Parazzini F (1993). Long-term impact of reproductive factors on cancer risk. Int J Cancer 53: 215-219.
46. La Vecchia C, Altieri A, Franceschi S, Tavani A (2001). Oral contraceptives and cancer: an update. Drug Safety 24: 741-754.
47. La Vecchia C, Franceschi S, Levi F (2003). Epidemiological research on cancer with a focus on Europe. Eur J Cancer Prev 12: 5-14.
48. Lyon JL, Gardner JW, West DW, et al. (1987). Smoking and carcinoma in situ of the uterine cervix. Cancer Epidemiol Biomarkers Prev 4: 415-428.
49. Medeiros R, Morais A, Vasconcelos A, Costa S, et al. (2002a). Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer. Eur J Cancer Prev 11: 343-350.
50. Medeiros R, Morais A, Vasconcelos A, et al. (2002b). The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population. J Hum Genet 47: 413-418.
51. Medeiros R, Vasconcelos A, Costa S, et al. (2003). Steroid hormone genotypes ARStul and ER325 are linked to the progression of human prostate cancer. Cancer Genet Cytogenet 141: 91-96.
52. Medeiros R, Vasconcelos A, Costa S, et al. (2004a). Metabolic susceptibility genes and prostate cancer risk in a southern European population: the role of glutathione S-transferases GSTM1, GSTM3 and GSTT1 genetic polymorphisms. Prostate 58: 414-420.
53. Medeiros R, Soares R, Vasconcelos A, et al. (2004b). Glutathione S-transferase genotype GSTM1 as a predictor of elevated angiogenic phenotype in patients with early onset breast cancer. Angiogenesis 7: 53-58.
54. Miller K (2003). Estrogen and DNA damage: the silent source of breast cancer? J Natl Cancer Inst 95: 100-102.
55. Minkoff H, Feldman JG, Striker HD, et al. (2004). Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women. J Infect Dis 189: 1821-1828.
56. Moreno V, Bosh X, Muñoz N, et al. (2002). Effect of oral contraceptives on risk of cervical cancer in women with papillomavirus infection: the IARC multicentric case-control study. Lancet 359: 1085-1092.
57. Muñoz N, Franceschi S, Boseti C, et al. (2002). Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 359: 1093-1101.
58. Palefsky JM, Holly EA (2003). Immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr 31: 41-46.
59. Parkin DM, Bray F, Ferlay J, Pisani P (2001). Estimating the world cancer burden: Globocan. Int J Cancer 94: 153-156.
60. Pater MM, Mittal R, Pater A (1994). Role of steroid hormones in potentiating transformation of cervical cells by human papillomaviruses. Trends Microbiol 2: 229-234.
61. Peters RK, Thomas D, Hagan DG, et al. (1986). Risk factors for invasive cervical cancer among Latinas and non-latinas in Los Angeles county. J Natl Cancer Inst 77: 1063-1077.
62. Pinheiro PS, Tyczyński JE, Bray F, Matos E, Parkin DM (2003). Cancer incidence and mortality in Portugal. Eur J Cancer 39: 2507-2520.
63. Plummer M, Franceschi S (2002). Strategies for HPV prevention. Virus Res 89: 285-293.
64. Plummer M, Herrero R, Franceschi S, et al. (2003). Smoking and cervical cancer: pooled analyses of the IARC multi-centric case-control study. Cancer Causes Control 14: 805-814.
65. Reeves WC, Brinton LA, Garcia M, et al. (1989). Human papillomavirus infection and cervical cancer in Latin America. N Engl J Med 320: 1437-1441.
66. Santos C, Muñoz N, Klug S, et al. (2001). HPV types and cofactors causing cervical cancer in Peru. Br J Cancer 85: 966-971.
67. Schiffman M, Brinton L, Holly E, et al. (1987). Regarding mutagenic mucus in the cervix of smokers. J Natl Cancer Inst 78: 590-591.
68. Schlecht NF, Platt RW, Negassa A, et al. (2003). Modelling the time dependence of the association between human papillomavirus and cervical cancer precursor lesions. Am J Epidemiol 158: 878-886.
69. Schneider A, Hotz M, Gissmann L (1987). Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer 40: 198-201.
70. Smith JS, Herrero R, Bosetti C, et al. (2002). Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 94: 1604-1613.
71. Solomon D, Davey D, Kurman R, et al. (2002). The 2001 Bethesda System: terminology for reporting cervical cytology. JAMA 287: 2114-2119.
72. Storey A, Thomas M, Kalita A, et al. (1998). Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393: 229-234.
73. Szarewski A, Jarvis MJ, Sasieni P, et al. (1996). Effect of smoking cessation on cervical lesion size. Lancet 347: 941-943.
74. Szarewski A, Maddox P, Royston P, et al. (2001). The effect of stopping smoking on cervical Langerhans' cells and lymphocytes. Br J Obstet Gynecol 108: 295-303.
75. Tay SK, Tay KJ (2004). Passive cigarette smoking is a risk factor in cervical neoplasia. Gynecol Oncol 93: 116-120.
76. Visser JT, Hoogeboom BN, et al. (2003). HLA class I alleles and cervical neoplasia. J Infect Dis 187: 1675-1676.
77. Walboomers JM, Jacobs MV, Manos MM, et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 18: 12-19.
78. Winkelstein WJR (1990). Smoking and cervical cancer - current status: a review. Am J Epidemiol 131: 945-957.
79. Zehbe I, Tachezy R, Mytilineos J, et al. (2001). Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer 94: 711-716.